Skip to main content
University of California San Francisco
About UCSF
Search UCSF
UCSF Medical Center
Radiology
Search
About
People
Opportunity and Outreach
Wellbeing and Professional Climate
Make a Gift
Contact Us
Patient Care
For Health Professionals
For Patients
Services Offered
Clinical Divisions
Patient Safety
Education
Diagnostic Radiology Residency
Integrated IR Residency
Independent IR Residency
NucMed Residency & Fellowship
Fellowships
T32 Program
Medical Student Education
Master of Science in Biomedical Imaging (MSBI)
Continuing Medical Education
The Margulis Society for Alumni
Distinguished Lecture Series
Research
Research Directory
Imaging Research Symposium
Research Conference
UCSF Radiology at RSNA
Core Services
Academic Affairs
Academic Recruitment
Academic Advancement
Development & Courses
Faculty Mentoring
Faculty Thrive Guide
Celebrating Faculty & Alumni
Department Committees
FAQs
Locations
News
Events
Honors and Awards
Department Publications
Breadcrumb
Home
/
About
/
People
/
Nicholas Fidelman, MD
/
Publications
Nicholas Fidelman, MD's Publications
ACR Appropriateness Criteria® Management of Iliac Artery Occlusive Disease: 2024 Update.
Intra-arterial Peptide Receptor Radionuclide Therapy for the Treatment of Hepatic Neuroendocrine Tumor Metastases: Hope or Hype?
ACR Appropriateness Criteria® Central Venous Access Device and Site Selection.
ACR Appropriateness Criteria® Dialysis Fistula Malfunction.
ACR Appropriateness Criteria® Lower Extremity Chronic Venous Disease.
Contemporary applications of Y90 for the treatment of hepatocellular carcinoma.
Cost-Effectiveness Analysis of Interventional Liver-Directed Therapies for a Single, Small Hepatocellular Carcinoma in Liver Transplant Candidates.
Cost-effectiveness analysis of interventional liver-directed therapies for downstaging of HCC before liver transplant.
Ethiodized oil as an imaging biomarker after conventional transarterial chemoembolization.
Liver-Directed Therapy for Neuroendocrine Tumor Metastases in the Era of Peptide Receptor Radionuclide Therapy.
Per-patient Negative Predictive Value of the CT and MRI Liver Imaging Reporting and Data System Version 2018 Treatment Response Algorithm for Hepatocellular Carcinoma.
Socioeconomic and Survival Analysis of Radioembolization in Patients with Intrahepatic Cholangiocarcinoma: A Propensity Score-Adjusted Study.
ACR Appropriateness Criteria® Radiologic Management of Mesenteric Ischemia: 2022 Update.
Correction to: A Leap from TACE to TACE Potentiated by Immune Response Modulation and Angiogenesis Inhibition for Patients with Intermediate-Stage Hepatocellular Carcinoma: LEAP-012 Phase 3 Randomized Control Trial Protocol.
Phase I prospective trial of TAS-102 (trifluridine and tipiracil) and radioembolization with 90Y resin microspheres for chemo-refractory colorectal liver metastases.
A Leap from TACE to TACE Potentiated by Immune Response Modulation and Angiogenesis Inhibition for Patients with Intermediate-Stage Hepatocellular Carcinoma: LEAP-012 Phase 3 Randomized Control Trial Protocol.
ACR Appropriateness Criteria® Radiologic Management of Lower Gastrointestinal Tract Bleeding: 2021 Update.
Frontiers of therapy for hepatocellular carcinoma.
Hepatic Toxicity After Selective Chemoembolization Is Associated With Decreased Survival Among Patients With Hepatocellular Carcinoma.
Molecular and Radiological Features of Microsatellite Stable Colorectal Cancer Cases With Dramatic Responses to Immunotherapy.
Non-operative management of biliary complications after Liver Transplantation in pediatric patients: A 30-year experience.
Onyx embolization of an enlarging arterioportal pancreatic AVM using a balloon-occlusion microcatheter.
Outcomes after high-dose radiation in the management of neuroendocrine neoplasms.
Phase I Trial on Arterial Embolization with Hypoxia Activated Tirapazamine for Unresectable Hepatocellular Carcinoma.
The Key Role of Staging Definitions for Assessment of Downstaging for Hepatocellular Carcinoma.
ACR Appropriateness Criteria® Radiologic Management of Iliofemoral Venous Thrombosis.
Carcinoid Crisis-Induced Acute Systolic Heart Failure.
Holmium-166 radioembolisation after peptide receptor radionuclide therapy: much needed data to help inform future research.
Intermediate to Long-Term Clinical Outcomes of Percutaneous Cryoablation for Renal Masses.
Intraarterial Peptide Receptor Radionuclide Therapy Using 90Y-DOTATOC for Hepatic Metastases of Neuroendocrine Tumors.
Liver-Directed Therapy for Neuroendocrine Tumor Liver Metastases in the Era of Peptide Receptor Radionuclide Therapy.
NANETS/SNMMI Consensus Statement on Patient Selection and Appropriate Use of 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy.
Outcomes of transjugular liver biopsies for liver transplant recipients with bicaval and piggyback hepatic vein anastomoses.
ACR Appropriateness Criteria® Radiologic Management of Venous Thromboembolism-Inferior Vena Cava Filters.
Endoscopic Magnetic Compression Anastomosis For Small Bowel Bypass in a High Operative Risk Setting.
Outcomes after Peripancreatic Fluid Drainage in Patients with Simultaneous Pancreas-Kidney Transplantation.
Periprocedural Management of Patients Undergoing Liver Resection or Embolotherapy for Neuroendocrine Tumor Metastases.
Prospective Phase II trial of drug-eluting bead chemoembolization for liver transplant candidates with hepatocellular carcinoma and marginal hepatic reserve.
Safety and Efficacy of Transjugular Liver Biopsy in Patients with Left Lobe-Only Liver Transplants.
90Y Radioembolization for Hepatic Malignancy in Patients with Previous Biliary Intervention: Multicenter Analysis of Hepatobiliary Infections.
Operator Dose Reduction during Transjugular Liver Biopsy Using a Radiation-Attenuating Drape: A Prospective, Randomized Study.
ACR Appropriateness Criteria® Radiologic Management of Mesenteric Ischemia.
Radiation Dose Reduction during Uterine Fibroid Embolization Using an Optimized Imaging Platform.
Catheter directed interventions for acute deep vein thrombosis.
Embolotherapy for Neuroendocrine Tumor Liver Metastases: Prognostic Factors for Hepatic Progression-Free Survival and Overall Survival.
Imaging prediction of residual hepatocellular carcinoma after locoregional therapy in patients undergoing liver transplantation or partial hepatectomy.
Intention to treat outcome of T1 hepatocellular carcinoma with the "wait and not ablate" approach until meeting T2 criteria for liver transplant listing.
Letters to the Editor.
Radioembolization with 90Y glass microspheres for the treatment of unresectable metastatic liver disease from chemotherapy-refractory gastrointestinal cancers: final report of a prospective pilot study.
Rate of observation and inter-observer agreement for LI-RADS major features at CT and MRI in 184 pathology proven hepatocellular carcinomas.
Safety and Efficacy of Doxorubicin Drug-Eluting Embolic Chemoembolization of Hepatocellular Carcinoma Supplied by Extrahepatic Collateral Arteries.
Benign Biliary Strictures: Diagnostic Evaluation and Approaches to Percutaneous Treatment.
Crossed legs: an unexpected occurrence during an ALN filter placement.
Downstaging of hepatocellular cancer before liver transplant: long-term outcome compared to tumors within Milan criteria.
Hemothorax resulting from injury to the right inferior phrenic artery following transhepatic procedures.
Imaging Predictors of Elevated Lung Shunt Fraction in Patients Being Considered for Yttrium-90 Radioembolization.
Implications of discordant findings between hepatic angiography and cross-sectional imaging in transplant candidates with hepatocellular carcinoma.
Patient Radiation Dose Reduction during Transarterial Chemoembolization Using a Novel X-Ray Imaging Platform.
Periprocedural Patient Care.
Reassessing the boundaries of liver transplantation for hepatocellular carcinoma: Where do we stand with tumor down-staging?
Retained Placenta Accreta Mimicking Choriocarcinoma.
Transarterial Chemoembolization and (90)Y Radioembolization for Hepatocellular Carcinoma: Review of Current Applications Beyond Intermediate-Stage Disease.
90Y glass microspheres for the treatment of unresectable metastatic liver disease from chemotherapy-refractory gastrointestinal cancers: a pilot study.
Hepatic artery and biliary complications in liver transplant recipients undergoing pretransplant transarterial chemoembolization.
Hook, line, and sinker: hook wire localization of a retained suture needle in the perineum.
The inferior emissary vein: a reliable landmark for right adrenal vein sampling.
ACR Appropriateness Criteria radiologic management of benign and malignant biliary obstruction.
Caval penetration by retrievable inferior vena cava filters: a retrospective comparison of Option and Günther Tulip filters.
Clinical outcomes of percutaneous drainage of breast fluid collections after mastectomy with expander-based breast reconstruction.
Distribution of reported StarClose SE vascular closure device complications in the manufacturer and user facility device experience database.
Efficacy of TACE in TIPS patients: comparison of treatment response to chemoembolization for hepatocellular carcinoma in patients with and without a transjugular intrahepatic portosystemic shunt.
Factors associated with outcomes and response to therapy in patients with infiltrative hepatocellular carcinoma.
Failure of filter reexpansion during unsuccessful retrieval of Option inferior vena cava filter.
Management of well-differentiated gastrointestinal neuroendocrine tumors metastatic to the liver.
Outcomes of metallic biliary stent insertion in patients with malignant bilobar obstruction.
Percutaneous interventions in failing "necklace" hemodialysis grafts: long-term outcomes.
Preoperative CT-Guided percutaneous wire localization of ground glass pulmonary nodules with a modified Kopans wire.
Reply to Re: Hepatotoxicity after transarterial chemoembolization and transjugular intrahepatic portosystemic shunt: do two rights make a wrong?
ACR Appropriateness Criteria radiologic management of hepatic malignancy.
ACR appropriateness criteria® radiologic management of thoracic nodules and masses.
Hepatotoxicity after transarterial chemoembolization and transjugular intrahepatic portosystemic shunt: do two rights make a wrong?
Imaging predictors of the response to transarterial chemoembolization in patients with hepatocellular carcinoma: a radiological-pathological correlation.
Morbidity and mortality following transarterial liver chemoembolization in patients with hepatocellular carcinoma and synthetic hepatic dysfunction.
Percutaneous transhepatic balloon dilation of biliary-enteric anastomotic strictures after surgical repair of iatrogenic bile duct injuries.
Pretransplant prediction of microvascular invasion in patients with hepatocellular carcinoma: added value of diffusion-weighted magnetic resonance imaging.
Reducing the rate of repeat imaging: import of outside images to PACS.
The transjugular intrahepatic portosystemic shunt: an update.
Transcatheter arterial embolization for upper gastrointestinal nonvariceal hemorrhage: is empiric embolization warranted?
Accuracy of percutaneous transhepatic cholangiography in predicting the location and nature of major bile duct injuries.
Entrapment of the StarClose Vascular Closure System after attempted common femoral artery deployment.
Mixed hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma in patients undergoing transplantation for hepatocellular carcinoma.
Rex shunt preoperative imaging: diagnostic capability of imaging modalities.
Transcatheter arterial embolization of spontaneous life-threatening extraperitoneal hemorrhage.
Arterial embolization for the management of gastrointestinal hemorrhage from metastatic renal cell carcinoma.
Complications associated with the percutaneous insertion of fiducial markers in the thorax.
Management of recurrent airway strictures in lung transplant recipients using AERO covered stents.
Hepatic arterial injuries after percutaneous biliary interventions in the era of laparoscopic surgery and liver transplantation: experience with 930 patients.
Reperfusion of pulmonary arteriovenous malformations after successful embolotherapy with vascular plugs.
Percutaneous interventions in subclavian artery-to-contralateral subclavian vein "necklace" hemodialysis grafts: experience in five patients.
Orthopedic spinal and hip prostheses: effects of magnetic susceptibility artifacts during MR arteriography and venography of abdomen and pelvis.
Hepatocellular carcinoma: regional therapy with a magnetic targeted carrier bound to doxorubicin in a dual MR imaging/ conventional angiography suite--initial experience with four patients.
Postoperative evaluation of complex aortovisceral and aortorenal reconstructions by magnetic resonance angiography.
Experimental renal artery embolization in a combined MR imaging/angiographic unit.
Evaluation of active bleeding into hematomas by technetium-99m red blood cell scintigraphy before angiography.
Real-time MR properties of particulate embolic agents tested in a dynamic flow model.
Conditional expression of a Gi-coupled receptor causes ventricular conduction delay and a lethal cardiomyopathy.
Vector unpacking as a potential barrier for receptor-mediated polyplex gene delivery.
